A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21).
Jung HA, Kim M, Kim HS, Kim JH, Choi YH, Cho J, Park JH, Park KU, Ku BM, Park S, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ.
Jung HA, et al. Among authors: ku bm.
J Thorac Oncol. 2023 Feb;18(2):223-231. doi: 10.1016/j.jtho.2022.10.008. Epub 2022 Oct 25.
J Thorac Oncol. 2023.
PMID: 36307042
Free article.
Clinical Trial.